These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2209919)

  • 21. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft FC
    Nephrol Dial Transplant; 1996 Jan; 11(1):165-72. PubMed ID: 8649628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of the ocular form of Behçet disease with cyclosporin A].
    Pahlitzsch T; Wyrobisch W; Kämpe C; Wiederholt M
    Klin Monbl Augenheilkd; 1990 Jun; 196(6):466-9. PubMed ID: 2376943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney biopsies in control or cyclosporin A-treated psoriatic patients. International Kidney Biopsy Registry of Cyclosporin A (Sandimmun) in Autoimmune Diseases.
    Br J Dermatol; 1990 Jun; 122 Suppl 36():95-100. PubMed ID: 2369573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of lithium clearance studies in the early detection of cyclosporin A (CsA) nephrotoxicity: a protocol of renal function assessment with CsA therapy.
    Dick AD; Towler HM; Whiting P; Forrester JV
    Curr Eye Res; 1992; 11 Suppl():215-8. PubMed ID: 1424748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversibility of cyclosporin nephrotoxicity after three months' treatment.
    Chapman JR; Griffiths D; Harding NG; Morris PJ
    Lancet; 1985 Jan; 1(8421):128-30. PubMed ID: 2857212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with immunosuppressive therapy in patients with pars planitis: experience of a reference centre in Mexico.
    Serna-Ojeda JC; Pedroza-Seres M
    Br J Ophthalmol; 2014 Nov; 98(11):1503-7. PubMed ID: 24985727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin-associated nephropathy in patients with autoimmune diseases.
    Mihatsch MJ; Bach JF; Coovadia HM; Førre O; Moutsopoulos HM; Drosos AA; Siamopoulos KC; Noël LH; Ramsaroop R; Hällgren R
    Klin Wochenschr; 1988 Jan; 66(2):43-7. PubMed ID: 3347004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose Cyclosporin a in uveitis a long-term follow-up.
    Cohen E; Raz J; Maftzir G; Benezra D
    Ocul Immunol Inflamm; 1993; 1(3):195-202. PubMed ID: 22822773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal haemodynamics of cyclosporin A nephrotoxicity in children with juvenile dermatomyositis.
    Peters AM; Heckmatt JZ; Hasson N; Henderson BL; el-Meleigy D; Rose ML; Dubowitz V
    Clin Sci (Lond); 1991 Aug; 81(2):153-9. PubMed ID: 1653658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of cyclosporin in the management of steroid dependent non-necrotising scleritis.
    Hakin KN; Ham J; Lightman SL
    Br J Ophthalmol; 1991 Jun; 75(6):340-1. PubMed ID: 2043575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin in juvenile dermatomyositis.
    Heckmatt J; Hasson N; Saunders C; Thompson N; Peters AM; Cambridge G; Rose M; Hyde SA; Dubowitz V
    Lancet; 1989 May; 1(8646):1063-6. PubMed ID: 2566009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study.
    Yocum DE; Klippel JH; Wilder RL; Gerber NL; Austin HA; Wahl SM; Lesko L; Minor JR; Preuss HG; Yarboro C
    Ann Intern Med; 1988 Dec; 109(11):863-9. PubMed ID: 3190040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis treated with ciclosporin.
    Nyberg-Hansen R; Gjerstad L
    Acta Neurol Scand; 1988 Apr; 77(4):307-13. PubMed ID: 3389081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term cyclosporin for psoriasis.
    Griffiths CE; Powles AV; McFadden J; Baker BS; Valdimarsson H; Fry L
    Br J Dermatol; 1989 Feb; 120(2):253-60. PubMed ID: 2923798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin A in cardiac transplantation: medium-term results in 62 patients.
    Hakim M; Wallwork J; English T
    Ann Thorac Surg; 1988 Nov; 46(5):495-501. PubMed ID: 3056298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal function and blood pressure in patients treated with cyclosporin A for uveitis.
    Deray G; Le Hoang P; Cacoub P; Aupetit B; Mertani A; Martinez F; Rottembourg J
    Eur J Clin Pharmacol; 1988; 34(6):601-4. PubMed ID: 3169111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.
    Tugwell P; Bombardier C; Gent M; Bennett KJ; Bensen WG; Carette S; Chalmers A; Esdaile JM; Klinkhoff AV; Kraag GR
    Lancet; 1990 May; 335(8697):1051-5. PubMed ID: 1970370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Kolkin S; Nahman NS; Mendell JR
    Neurology; 1987 Jan; 37(1):147-9. PubMed ID: 3796829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal function and blood pressure in psoriatic patients treated with cyclosporin A.
    Feutren G; Abeywickrama K; Friend D; von Graffenried B
    Br J Dermatol; 1990 Jun; 122 Suppl 36():57-69. PubMed ID: 2196085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporin A in atopic dermatitis.
    Ross JS; Camp RD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():41-5. PubMed ID: 2196083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.